Company profile: Biodextris
1.1 - Company Overview
Company description
- Provider of analytical and process development, early-phase clinical manufacturing, packaging, and scalable bioproduction services for vaccines and biologics. Offers quality control testing and validation to ensure regulatory compliance, with tailored development solutions for biotech and pharmaceutical companies.
Products and services
- Biologics Manufacturing & Development: Biodextris engineers vaccines and biologic products via development, early-phase clinical manufacturing, and packaging for biotech and pharmaceutical clients, delivering clinical-grade components and process development expertise
- Analytical Services - Quality Testing & Validation: Biodextris delivers regulatory-compliant quality control testing and validation for vaccines and biologics, supplying documented conformity to standards to support vaccine and biologic programs
- Bioproduction Services - Scalable & Robust Solutions: Biodextris produces scalable bioproduction systems for manufacturing vaccines and therapeutic products, offering robust capacity for clients developing biologics.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biodextris
Arcus Medica
HQ: United States
Website
- Description: Provider of medical and scientific communications consulting services with full-service capabilities and expertise in oncology, hematology, transplant, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arcus Medica company profile →
INCOG BioPharma Services
HQ: United States
Website
- Description: Provider of injectable drug product services, including formulation development, analytical method development, process scale up, and formulation/filling of vials, syringes, and cartridges for clinical and commercial manufacturing. Offers QC chemistry and microbiology testing, inspection, labeling, packaging, device assembly, and material/finished product storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full INCOG BioPharma Services company profile →
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
Metrion Biosciences
HQ: United Kingdom
Website
- Description: Provider of specialist ion channel contract research for drug discovery to pharmaceutical and bioscience customers worldwide, including validated ion channel screening, CiPA-compliant human cardiac ion channel assays (GLP hERG), neuroscience ion channel and neurotoxicology screening, translational phenotypic assays, integrated ion channel research programs, and HTS for hit finding, lead optimization, and selectivity profiling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metrion Biosciences company profile →
LakePharma
HQ: United States
Website
- Description: Provider of integrated biologics CRDMO services from discovery and engineering to development and GMP manufacturing. Offerings include antibody discovery and engineering, protein engineering and production, cell line development, phage and yeast display, hybridoma technologies, viral vector platforms (Baculovirus, AAV, Lentivirus), plasmid DNA services, and ISO 13485:2016 GMP manufacturing of mRNA, antibodies, proteins, and vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LakePharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biodextris
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biodextris
2.2 - Growth funds investing in similar companies to Biodextris
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biodextris
4.2 - Public trading comparable groups for Biodextris
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →